HCB101 Trial
Phase 1
60
about 6.1 years
18+
4 sites in FL, NC, SC +1
What this study is about
This trial is testing a new treatment called HCB101 for advanced solid tumors or relapsed non-Hodgkin lymphoma. The goal is to see if it's safe and effective, as well as identify any side effects that may occur in adults aged 18 years or older.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take HCB101
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Number of subjects with MTD of HCB101, Number/incidence and percentage of subjects with adverse events, including ADA.
Secondary: Area under the plasma concentration versus time curve (AUC) of HCB101, Disease Control Rate (DCR), Duration of Response (DoR), Overall Rate Response (ORR), Peak Plasma Concentration (Cmax) of HCB101, Progression-Free Survival (PFS), Terminal elimination half-life (t1/2) of HCB101, Time to maximum drug concentration in plasma (Tmax) of HCB101
Oncology